Senior Vice-Dean's Message
Welcome to Duke-NUS Research.
Duke-NUS is proud of the internationally recognized research programs conducted by our faculty; programs that are already yielding tangible impact in the clinic and in the biopharmaceutical arena. Our five world-class Signature Research Programmes (SRPs)—in Cancer and Stem Cell Biology, Neuroscience and Behavioural Disorders, Cardiovascular and Metabolic Disorders, Emerging Infectious Diseases, and Health Systems and Services Research—conduct leading research in strategic focus areas of importance to the region and beyond. Of course, our strengths and successes in research extend beyond these areas, and I invite you to explore the web pages of not only our SRPs, but also our Centres and Joint Institutes, to learn more. Collectively, these research efforts aim to make an impact on Singapore’s biomedical landscape, health systems, and biopharmaceutical industries.
Duke-NUS, in collaboration with its Partner in Academic Medicine, SingHealth, and parent universities Duke and NUS, has become a major avenue for innovation that is already being translated into health solutions and commercial impact. Duke-NUS adopts a multi-faceted, and multi-disciplinary approach, leveraging on state-of-the-art technology platforms that are opening up new horizons for research. We are particularly excited by new initiatives to expand our scientific efforts in data science and health informatics, which should aid in identifying new areas for scientific investigation as well as in optimizing clinical care. We will continue to enthusiastically grow and diversify our programs of scientific discovery and translation.
Our faculty and researchers collaborate with academic and healthcare institutions, government organisations, and pharmaceutical and biotechnology companies, both locally and internationally. Significant research discoveries have been made at Duke-NUS, and many of our researchers have been bestowed with accolades and awards from across the globe.
The SingHealth Duke-NUS Academic Medical Centre (AMC) harnesses the collective strengths of Duke-NUS’ medical education and research capabilities, and SingHealth’s clinical expertise. Through this partnership, clinical care, education and research are integrated, leading to improved healthcare and patient outcomes. Under the AMC umbrella, Duke-NUS-affiliated investigators undertake clinical research at hospitals, clinics and community-based sites across Singapore.
I invite you to explore the website to learn more about Duke-NUS’ research pursuits, researchers, and our extensive contributions to biomedical science and healthcare.
Professor Patrick J Casey
Senior Vice-Dean, Research